The Role Precision Medicine in the Field of Cancer Oncology

Dear Colleagues,

In recent years, the field of cancer treatment has seen transformative changes, particularly with the emergence of precision medicine as a groundbreaking approach. This paradigm shift empowers healthcare providers to customize therapies based on the unique genetic and molecular profile of each patient, moving away from the traditional one-size-fits-all model of cancer treatment approach. This special issue seeks to explore the cutting-edge developments, challenges, and future prospects of precision medicine in the field of cancer oncology.

Topics of Interest Include, but are not limited to:

• Genomic profiling and targeted therapies
• Artificial Intelligence and machine learning in diagnostic pathology
• Data analytics for treatment optimization
• individualized treatment plans
• Role of immunotherapy in precision medicine
• Real-world applications of precision medicine in oncology
• The development of precision medicine for pediatric oncology

We invite original research articles and reviews from researchers and clinicians to contribute to this multidisciplinary special issue. The aim is to create a comprehensive and insightful collection of articles that shed light on how precision medicine is revolutionizing cancer treatment, from bench to bedside.

Dr. Tze-Kiong Er
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• precision medicine
• cancer oncology
• genomic profiling
• artificial intelligence
• immunotherapy
• pediatric oncology
• treatment optimization